首页> 美国卫生研究院文献>Cardiovascular Diabetology >Combination therapy with pemafibrate (K-877) and pitavastatin improves vascular endothelial dysfunction in dahl/salt-sensitive rats fed a high-salt and high-fat diet
【2h】

Combination therapy with pemafibrate (K-877) and pitavastatin improves vascular endothelial dysfunction in dahl/salt-sensitive rats fed a high-salt and high-fat diet

机译:用Pemafibrate(K-877)和Pitavastatin的组合治疗改善了DAHL /盐敏大鼠的血管内皮功能障碍喂养高盐和高脂饮食

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Scheme of experimental protocol. We used 7-week-old male Dahl salt-sensitive rats. Rats were fed a normal diet (ND) (0.3% NaCl and 4.5% fat) or a high-salt and high-fat diet (HD) (8% NaCl and 29.4% fat). The rats were divided into five different groups and treated with vehicle, pitavastatin (0.3 mg/kg), pemafibrate (K-877) (0.5 mg/kg), or a combination of pitavastatin (0.3 mg/kg) and pemafibrate (K-877) (0.5 mg/kg) for 12 weeks. At 19 weeks, blood collection and evaluation of endothelium-dependent relaxations of thoracic aorta were performed
机译:实验方案。我们使用了7周龄雄性Dahl盐敏大鼠。大鼠喂养正常饮食(Nd)(0.3%NaCl和4.5%脂肪)或高盐和高脂饮食(HD)(8%NaCl和29.4%脂肪)。将大鼠分为五种不同的基团,并用载体,匹伐他汀(0.3mg / kg),Pemafibrate(K-877)(0.5mg / kg)或匹伐他汀(0.3mg / kg)和pemafibrate的组合(K- 877)(0.5 mg / kg)12周。在19周,进行血液收集和对胸部主动脉的内皮依赖性放松的评估

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号